A
AMED

AlphaQuest’s Amedisys AMED Stock Holding History

AlphaQuest’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,603
Closed -$612K – 2030
2025
Q1 		$612K Buy
+6,603
New +$609K 0.07% 457
2024
Q4 		– Sell
-579
Closed -$55.9K – 1690
2024
Q3 		$55.9K Sell
579
-6,759
-92% -$659K 0.01% 1391
2024
Q2 		$674K Buy
7,338
+3,842
+110% +$356K 0.09% 354
2024
Q1 		$322K Buy
+3,496
New +$328K 0.06% 507

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

AlphaQuest's AMED Position: Q2 2025 in Review

AlphaQuest sold out of Amedisys (AMED) in Q2 2025, closing a stake of 6,603 shares — an estimated $612K sold.

AlphaQuest first reported a position in AMED in Q1 2024 and held it in 4 quarters. The position peaked at $674K in Q2 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • AlphaQuest reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • AlphaQuest sold 6,603 Amedisys shares in Q2 2025, an estimated $612K.
  • AlphaQuest first reported a position in Amedisys in Q1 2024 and held it in 4 quarters.
  • AlphaQuest's Amedisys position peaked at $674K in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on AlphaQuest's 13F filing for Q2 2025, filed 31 Jul 2025.